Revolution Medicines Inc (NASDAQ:RVMD) has a beta value of 1.08 and has seen 1.07 million shares traded in the recent trading session. The company, currently valued at $7.23B, closed the recent trade at $38.90 per share which meant it gained $2.04 on the day or 5.52% during that session. The RVMD stock price is -60.41% off its 52-week high price of $62.40 and 25.01% above the 52-week low of $29.17. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.9 million shares traded. The 3-month trading volume is 1.52 million shares.
The consensus among analysts is that Revolution Medicines Inc (RVMD) is Buy stock at the moment, with a recommendation rating of 1.08. 1 analysts rate the stock as a Sell, while 1 rate it as Overweight. 0 out of 13 have rated it as a Hold, with 11 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -1.06.
Revolution Medicines Inc (NASDAQ:RVMD) trade information
Sporting 5.52% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the RVMD stock price touched $38.90 or saw a rise of 0.51%. Year-to-date, Revolution Medicines Inc shares have moved -11.07%, while the 5-day performance has seen it change 7.09%. Over the past 30 days, the shares of Revolution Medicines Inc (NASDAQ:RVMD) have changed -1.13%. Short interest in the company has seen 16.2 million shares shorted with days to cover at 12.04.
Wall Street analysts have a consensus price target for the stock at $67, which means that the shares’ value could jump 41.94% from the levels at last check today.. The projected low price target is $60.0 while the price target rests at a high of $82.0. In that case, then, we find that the latest price level in today’s session is -110.8% off the targeted high while a plunge would see the stock gain -54.24% from the levels at last check today..
Revolution Medicines Inc (RVMD) estimates and forecasts
The company’s shares have lost -22.87% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -27.80% over the past 5 years. Earnings growth for 2025 is a modest -28.14% while over the next 5 years, the company’s earnings are expected to decrease by -3.56%.
RVMD Dividends
Revolution Medicines Inc is expected to release its next earnings report on 2025-Feb-25 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Revolution Medicines Inc (NASDAQ:RVMD)’s Major holders
Insiders own 2.01% of the company shares, while shares held by institutions stand at 107.02% with a share float percentage of 109.21%. Investors are also buoyed by the number of investors in a company, with Revolution Medicines Inc having a total of 387.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 14.38 million shares worth more than $558.02 million. As of 2024-06-30, VANGUARD GROUP INC held 8.7066% of shares outstanding.
The other major institutional holder is WELLINGTON MANAGEMENT GROUP LLP, with the holding of over 13.66 million shares as of 2024-06-30. The firm’s total holdings are worth over $530.15 million and represent 8.2718% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . As of Dec 31, 2024 , the former fund manager holds about 2.93% shares in the company for having 5.45 shares of worth $207.75 million while later fund manager owns 4.48 shares of worth $170.62 million as of Mar 31, 2025 , which makes it owner of about 2.41% of company’s outstanding stock.
